HomeALXO • NASDAQ
ALX Oncology Holdings Inc
Follow
$0.49
1.78%
After Hours:(2.77%)+0.014
$0.50
Closed: Jun 18, 6:13:10 PM GMT-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 31.82M | -15.74% |
Net income | -30.75M | 13.57% |
Net profit margin | — | — |
Earnings per share | -0.48 | 32.64% |
EBITDA | -31.61M | 15.82% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 97.83M | -37.86% |
Total assets | 120.90M | -43.15% |
Total liabilities | 32.61M | -32.71% |
Total equity | 88.30M | — |
Shares outstanding | 53.44M | — |
Price to book | 0.30 | — |
Return on assets | -59.22% | — |
Return on capital | -67.57% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -30.75M | 13.57% |
Cash from operations | -24.66M | 34.97% |
Cash from investing | 27.65M | 4.43% |
Cash from financing | 65.00K | -97.89% |
Net change in cash | 3.05M | 136.43% |
Free cash flow | -13.92M | 47.99% |
Previous close
$0.50
Day range
$0.48 - $0.50
Year range
$0.41 - $8.78
Market cap
25.76M USD
Avg Volume
451.20K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2015
Headquarters
Website
Employees
65
